<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-30598" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Tricuspid Stenosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Golamari</surname>
            <given-names>Reshma</given-names>
          </name>
          <aff>Drexel University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Shams</surname>
            <given-names>Pirbhat</given-names>
          </name>
          <aff>The Aga Khan University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alahmadi</surname>
            <given-names>Mohamed H.</given-names>
          </name>
          <aff>University of Health Sciences, Lahore</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bhattacharya</surname>
            <given-names>Priyanka T.</given-names>
          </name>
          <aff>University of Pennsylvania</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Reshma Golamari declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Pirbhat Shams declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mohamed Alahmadi declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Priyanka Bhattacharya declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>6</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-30598.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Tricuspid stenosis is a rare valvular abnormality characterized by narrowing of the tricuspid valve that can lead to elevated right atrial pressures and systemic congestion.&#x000a0;This condition often occurs with other valvular abnormalities, most commonly rheumatic mitral valve disease. Tricuspid stenosis can be broadly classified into&#x000a0;3 categories: acquired, congenital, and iatrogenic, and can result from various causes, including rheumatic heart disease, carcinoid syndrome, systemic lupus erythematosus, and congenital defects. Patients may present with symptoms such as fatigue, exertional dyspnea, and systemic congestion, with prognosis depending on the underlying cause and degree of ventricular dysfunction.</p>
        <p>Clinicians participating in this course gain comprehensive knowledge and skills related to diagnosing, managing, and treating tricuspid stenosis, enhancing their understanding of the pathophysiology, clinical manifestations, and diagnostic approaches for tricuspid stenosis. Participants also learn about treatment modalities, including medical management, surgical interventions, and percutaneous procedures. This course also provides valuable insights into interprofessional collaboration, communication strategies, and care coordination&#x02014;enabling clinicians to deliver patient-centered care that improves outcomes and enhances patient safety.&#x000a0;</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate tricuspid stenosis from other valvular abnormalities in terms of clinical presentation.</p></list-item><list-item><p>Select appropriate tests to assess&#x000a0;suspected&#x000a0;tricuspid stenosis cases.</p></list-item><list-item><p>Apply evidence-based treatment strategies tailored to the individual needs of patients diagnosed with tricuspid stenosis.</p></list-item><list-item><p>Collaborate with colleagues across various specialties to ensure timely and appropriate management of tricuspid stenosis, including preoperative evaluation, procedural planning, and postoperative care.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30598&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30598">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-30598.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Tricuspid stenosis is a rare valvular abnormality characterized by tricuspid valve narrowing. This condition increases the pressure gradient between the right atrium and ventricle, causing systemic congestion and&#x000a0;reduced right ventricular output. Isolated tricuspid stenosis is uncommon. This&#x000a0;condition typically occurs along with other valvular abnormalities, most frequently mitral valve pathology,&#x000a0;as a complication of rheumatic heart disease.<xref ref-type="bibr" rid="article-30598.r1">[1]</xref></p>
      </sec>
      <sec id="article-30598.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Tricuspid stenosis is the narrowing of the tricuspid orifice that obstructs blood flow from the right atrium to the right ventricle. The right atrium hypertrophies and distends, and sequelae of right heart disease-induced heart failure develop but without right ventricular dysfunction.&#x000a0;The right ventricle remains underfilled and small. The cause of tricuspid stenosis can be broadly classified into&#x000a0;3 categories: acquired, congenital, and iatrogenic.<xref ref-type="bibr" rid="article-30598.r2">[2]</xref></p>
        <p>
<bold>Acquired Tricuspid Stenosis</bold>
</p>
        <p>Rheumatic heart disease is the most common cause of acquired tricuspid stenosis. The condition almost always occurs in conjunction with mitral stenosis.&#x000a0;In a series of 173 patients with rheumatic heart disease, 15 had tricuspid stenosis&#x000a0;<xref ref-type="bibr" rid="article-30598.r3">[3]</xref></p>
        <p>Large infected vegetations can cause relative stenosis.<xref ref-type="bibr" rid="article-30598.r4">[4]</xref> Carcinoid syndrome can&#x000a0;produce&#x000a0;isolated tricuspid stenosis or, more commonly, mixed regurgitant and stenosed lesions.<xref ref-type="bibr" rid="article-30598.r5">[5]</xref></p>
        <p>Systemic diseases that can cause tricuspid stenosis include systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome (APAS), known to cause nonbacterial thrombotic endocarditis.&#x000a0;Hypereosinophilic syndrome and endomyocardial fibrosis can also&#x000a0;give rise to tricuspid stenosis.<xref ref-type="bibr" rid="article-30598.r6">[6]</xref></p>
        <p>Benign tumors like&#x000a0;atrial myxomas can produce this valvular abnormality.<xref ref-type="bibr" rid="article-30598.r7">[7]</xref> Among metastatic tumors, renal and ovarian tumors are known to&#x000a0;metastasize and grow into the tricuspid orifice, causing stenosis.<xref ref-type="bibr" rid="article-30598.r8">[8]</xref></p>
        <p>
<bold>Congenital</bold>
</p>
        <p>Congenital tricuspid stenosis is very rare, arising from tricuspid deformities due to&#x000a0;deformed leaflets and chordae and displacement of the entire valve apparatus.&#x000a0;Tricuspid stenosis is usually found in conjunction with other cardiac abnormalities, such as:</p>
        <list list-type="bullet">
          <list-item>
            <p>Small-volume right ventricular sinus cavity</p>
          </list-item>
          <list-item>
            <p>Pulmonary atresia or severe pulmonary valvar stenosis and no ventricular septal defect</p>
          </list-item>
          <list-item>
            <p>Absent right ventricle sinus&#x000a0;and a&#x000a0;double-inlet single&#x000a0;left&#x000a0;ventricle</p>
          </list-item>
          <list-item>
            <p>Ventricular septal defect without pulmonary valvar atresia or severe stenosis</p>
          </list-item>
          <list-item>
            <p>Rhabdomyoma of ventricular septum</p>
          </list-item>
        </list>
        <p>Other less common causes of tricuspid stenosis include congenital abnormalities such as Ebstein anomaly&#x000a0;and metabolic or enzymatic abnormalities such as Fabry and Whipple diseases.<xref ref-type="bibr" rid="article-30598.r9">[9]</xref><xref ref-type="bibr" rid="article-30598.r10">[10]</xref></p>
        <p>
<bold>Iatrogenic</bold>
</p>
        <p>The presence of permanent pacing and fusion of implantable cardioverter defibrillator leads within subvalvular structures can cause tricuspid stenosis.<xref ref-type="bibr" rid="article-30598.r11">[11]</xref><xref ref-type="bibr" rid="article-30598.r12">[12]</xref> Tricuspid stenosis&#x000a0;may also occur after overzealous tricuspid valve repair for tricuspid regurgitation, eg, bioprosthetic tricuspid valve stenosis (a serious and late complication of tricuspid valve replacement).<xref ref-type="bibr" rid="article-30598.r13">[13]</xref>&#x000a0;</p>
        <p>Valvular disease linked to anorectic medications, such as fenfluramine, phentermine, and methysergide, can also lead to tricuspid narrowing. Prolonged use of these drugs is connected to thickened, fibrotic, and hypomobile tricuspid leaflets, leading to varying levels of valve stenosis and regurgitation.<xref ref-type="bibr" rid="article-30598.r14">[14]</xref><xref ref-type="bibr" rid="article-30598.r15">[15]</xref><xref ref-type="bibr" rid="article-30598.r16">[16]</xref>&#x000a0;Methysergide has been associated with tricuspid stenosis since 1974.<xref ref-type="bibr" rid="article-30598.r17">[17]</xref> Microdosing of certain psychedelic drugs can increase the risk of valvulopathy and tricuspid stenosis.<xref ref-type="bibr" rid="article-30598.r18">[18]</xref></p>
      </sec>
      <sec id="article-30598.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Tricuspid stenosis accounts for about 2.4% of all cases of organic tricuspid valve disease&#x000a0;and is commonly seen in young women.&#x000a0;This condition accounts for less than 1% of valvular heart diseases.<xref ref-type="bibr" rid="article-30598.r19">[19]</xref><xref ref-type="bibr" rid="article-30598.r20">[20]</xref>&#x000a0;In a study of 13,289 patients with primary valvular disease, tricuspid stenosis was found in 0.3%, followed only by pulmonary stenosis in 0.04%. At least 90% of these patients had rheumatic heart disease.<xref ref-type="bibr" rid="article-30598.r21">[21]</xref></p>
      </sec>
      <sec id="article-30598.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The primary result of tricuspid stenosis is right atrial pressure elevation and right-sided congestion. Tricuspid stenosis causes increased pressure between the right atrium and ventricle during diastole, amplified during inspiration and exercise, and reduced during expiration.&#x000a0;Increasing severity of tricuspid stenosis&#x000a0;leads to&#x000a0;failure to augment cardiac output&#x000a0;during exercise.&#x000a0;Clinically, tricuspid stenosis results in signs and symptoms of systemic congestion.</p>
        <p>The valves consist of an outer layer of valve endothelial cells (VECs) surrounding&#x000a0;3 layers of the extracellular matrix, each with a specialized function and interspersed with interstitial valve cells (VICs).<xref ref-type="bibr" rid="article-30598.r19">[19]</xref> Genetic or acquired (eg, environmental) causes that disrupt the normal organization and composition of the extracellular matrix and communication between VECs and VICs alter valve mechanics and interfere with the valve leaflet function, culminating in valve damage.<xref ref-type="bibr" rid="article-30598.r22">[22]</xref> Rheumatic tricuspid stenosis is characterized by diffuse fibrous thickening of the leaflets and fusion of 2 or 3 commissures. Leaflet thickening usually occurs without calcific deposits, and the anteroseptal commissure is most involved.</p>
        <p>Tricuspid stenosis in carcinoid syndrome is caused by the deposition of fibrous plaques through vasoactive substance-mediated reactions, mainly serotonin. The deposition of endocardial plaques results in plaque distortion, leading to&#x000a0;tricuspid stenosis and regurgitation. Methysergide and serotonin share common chemical properties. Methysergide, a synthetic ergot alkaloid, causes fibrotic&#x000a0;thickening and structural deterioration of the tricuspid valve.<xref ref-type="bibr" rid="article-30598.r23">[23]</xref>&#x000a0;</p>
        <p>SLE can lead to tricuspid stenosis. This condition may result in the formation of immune deposits and fibrous plaques, along with the development of Libman-Sacks endocarditis. The fibrous reaction can cause valve thickening and commissural fusion, while Libman-Sacks endocarditis can lead to valve obstruction.<xref ref-type="bibr" rid="article-30598.r24">[24]</xref> Incompletely developed leaflets, shortened or malformed chordae, a small annulus, or an abnormal number or size of papillary muscles may result in congenital tricuspid stenosis.<xref ref-type="bibr" rid="article-30598.r25">[25]</xref></p>
        <p>Limited data exist on the natural history of isolated tricuspid stenosis, often associated with rheumatic mitral valve disease. Like mitral stenosis, acquired tricuspid stenosis results from a chronic, slowly progressive disease process characterized by a gradual increase in stenosis severity and a slow onset of symptoms. The underlying cause influences the mortality rate associated with tricuspid stenosis.</p>
      </sec>
      <sec id="article-30598.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>History</bold>
</p>
        <p>Patients with tricuspid stenosis may present with features of systemic congestion and reduced cardiac output, frequently&#x000a0;with accompanying valvular heart disease such as mitral stenosis. Common symptoms include exertional dyspnea, fatigue, and exertional syncope.<xref ref-type="bibr" rid="article-30598.r26">[26]</xref><xref ref-type="bibr" rid="article-30598.r27">[27]</xref>&#x000a0;Patients often experience general fatigue and weakness due to low cardiac output. These symptoms may be accompanied by a loss of appetite and a history of weight loss. The patient may also describe a feeling of fast neck pulsations. Right hypochondriac pain may be due to the stretching of the Glisson capsule by the congested liver. Carcinoid tumors, if present, may manifest with skin flushing, diarrhea, palpitations, and fatigue.</p>
        <p>Clues to the possible etiology of the condition may be obtained from a thorough history. For example, patients may report signs and symptoms of a prior rheumatic fever episode. Infants may have the condition as a prenatal diagnosis. Chronic medical conditions, long-term use of certain medications, and prior surgical procedures may all be helpful during the clinical investigation.</p>
        <p>
<bold>Physical</bold>
</p>
        <p>The lungs are clear in patients with isolated tricuspid stenosis. Pulmonary edema often occurs due to a concomitant mitral valve pathology. The precordial examination may reveal&#x000a0;an opening snap followed by&#x000a0;a middiastolic rumble at the left 4th intercostal space&#x000a0;with a&#x000a0;shorter&#x000a0;duration and softer intensity than&#x000a0;a mitral stenosis murmur. The murmur and opening snap intensity increase with maneuvers that boost blood flow across the tricuspid valve, such as inspiration, leg raising, amyl nitrate inhalation, squatting, or exercise. The jugular venous pressure is elevated in tricuspid stenosis. Thus, the Kussmaul sign, or failure of&#x000a0;jugular venous pressure to&#x000a0;fall with inspiration, may also be seen.&#x000a0;Signs&#x000a0;of systemic congestion include leg edema, ascites, anasarca, and congestive hepatopathy.&#x000a0;</p>
      </sec>
      <sec id="article-30598.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of tricuspid stenosis may be complicated by the subtlety of symptoms in some patients and overlapping presentations in others&#x000a0;where it cooccurs with another cardiac pathology. Thus,&#x000a0;diagnostic testing&#x000a0;is usually critical to the comprehensive evaluation of this condition.</p>
        <p>
<bold>Laboratory Studies</bold>
</p>
        <p>Metabolic panels may reveal mildly elevated unconjugated bilirubin, alkaline phosphatase, or aminotransferases, usually related to hepatic congestion. Arterial blood gas analysis may show respiratory alkalosis with varying degrees of compensation in patients with persistent shortness of breath.<xref ref-type="bibr" rid="article-30598.r28">[28]</xref></p>
        <p>However, the laboratory findings&#x000a0;in most cases are nonspecific and potentially influenced by the underlying cause. For example, patients with SLE may manifest with pancytopenia and antinuclear antibody positivity.&#x000a0;Individuals with carcinoid syndrome may have elevated blood levels of&#x000a0;5-hydroxyindoleacetic acid and N-terminal pro-b-type natriuretic peptide, which are sensitive and specific&#x000a0;predictors of carcinoid heart disease.<xref ref-type="bibr" rid="article-30598.r29">[29]</xref></p>
        <p>
<bold>Chest Radiograph</bold>
</p>
        <p>Isolated tricuspid stenosis may manifest with right atrial enlargement and clear lung fields. When accompanying mitral stenosis, interstitial edema or straightening of the left heart border may be seen.&#x000a0;</p>
        <p>
<bold>Electrocardiogram&#x000a0;</bold>
</p>
        <p>An electrocardiogram may show P-pulmonale&#x02014;tall and peaked P waves&#x02014;as evidence of right atrial enlargement. Tall and peaked T waves are mainly observed in leads II, III, and aVF. At least 50% of patients&#x000a0;develop atrial fibrillation.&#x000a0;</p>
        <p>
<bold>Jugular Venous Pulse Tracing</bold>
</p>
        <p>The jugular venous pressure is elevated with a prominent or giant A wave classically greater in height than usually perceived. The conspicuous A wave is due to contraction of the right atrium against a stenosed tricuspid valve in sinus rhythm.</p>
        <p>If tricuspid regurgitation coexists or when the rhythm is not regular, as in atrial fibrillation and flutter, the A wave becomes undermined by a similarly elevated V wave. A slow y descent&#x000a0;may also be seen due to delayed emptying of the right atrium into the right ventricle.<xref ref-type="bibr" rid="article-30598.r30">[30]</xref>&#x000a0;</p>
        <p>
<bold>Transthoracic Echocardiogram&#x000a0;</bold>
</p>
        <p>A transthoracic echocardiogram (TTE) is performed to assess the valve area and gradients across the valve to determine the severity of tricuspid stenosis and guide management strategy (see <bold>Image</bold>. Tricuspid Stenosis on Transthoracic Echocardiography).&#x000a0;TTE parameters help establish the severity of the disease.<xref ref-type="bibr" rid="article-30598.r31">[31]</xref>&#x000a0;These TTE parameters are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Thickening and distortion of the tricuspid valve, with or without calcification</p>
          </list-item>
          <list-item>
            <p>Commissural fusion with doming of the valve</p>
          </list-item>
          <list-item>
            <p>Valve area less than 1 cm<sup>2</sup>&#x000a0;signifies severe tricuspid stenosis. This parameter is calculated&#x000a0;by dividing 190 with pressure half-time. The normal area of the tricuspid valve is 4 cm<sup>2</sup>.</p>
          </list-item>
          <list-item>
            <p>Transvalvular gradient across the tricuspid valve of more than 5 to 10 mm Hg at a heart rate of 70 beats per minute suggests severe stenosis. Gradients are affected by the patient's hemodynamic status.</p>
          </list-item>
          <list-item>
            <p>Significant tricuspid regurgitation that can potentially alter the management strategy. Surgical correction may be needed instead of percutaneous intervention.</p>
          </list-item>
          <list-item>
            <p>Pressure half-time of more than 190 msec</p>
          </list-item>
          <list-item>
            <p>Inflow-time velocity integral of more than 60 cm</p>
          </list-item>
          <list-item>
            <p>Right atrial enlargement</p>
          </list-item>
          <list-item>
            <p>Plethoric inferior vena cava</p>
          </list-item>
        </list>
        <p>
<bold>Cardiac Catheterization</bold>
</p>
        <p>Tricuspid stenosis manifests with a large right atrial A wave of 12 to 20 mm Hg and a mean diastolic gradient of 4 to 8 mm Hg across the tricuspid valve.&#x000a0;The mean gradient across the tricuspid valve is more significant in tricuspid stenosis, as an end-diastolic gradient may be absent due to the lower filling pressures on the right side of the heart.<xref ref-type="bibr" rid="article-30598.r32">[32]</xref>&#x000a0;Elevated&#x000a0;right atrial pressures with a slow fall in early diastole and a diastolic pressure gradient across the tricuspid valve are characteristic of tricuspid stenosis.</p>
      </sec>
      <sec id="article-30598.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Little evidence&#x000a0;exists regarding&#x000a0;the management and outcomes of tricuspid stenosis. Treatment centers&#x000a0;on addressing the underlying mechanical obstruction. Medical therapy has a limited role.&#x000a0;</p>
        <p>
<bold>Medical</bold>
</p>
        <p>Loop diuretics may help relieve systemic and hepatic congestion in patients with severe, symptomatic tricuspid stenosis.<xref ref-type="bibr" rid="article-30598.r33">[33]</xref> Caution is advised, however, since diuretics may excessively decrease the preload in patients with a low output state. Not every tricuspid stenosis case requires invasive intervention.&#x000a0;SLE&#x000a0;and&#x000a0;APAS&#x000a0;treatment may reduce the &#x0201c;coating&#x0201d; over the valves and chordae and,&#x000a0;subsequently,&#x000a0;stenosis and regurgitation.<xref ref-type="bibr" rid="article-30598.r34">[34]</xref> Fenfluramine or methysergide withdrawal has been associated with valve normalization.<xref ref-type="bibr" rid="article-30598.r35">[35]</xref> However, advanced cases&#x000a0;often warrant&#x000a0;surgical therapy&#x000a0;besides&#x000a0;medical management.</p>
        <p>
<bold>Intervention</bold>
</p>
        <p>Percutaneous valvotomy can be performed for patients with unacceptable surgical risk and absence of tumor, thrombus, vegetation, and insignificant or mild tricuspid regurgitation.&#x000a0;Surgical correction (repair or replacement) is suggested for patients with low-to-moderate surgical risk or significant regurgitation. Surgical correction is recommended for patients with coexisting valvular heart diseases, such as mitral stenosis.<xref ref-type="bibr" rid="article-30598.r36">[36]</xref></p>
        <p>Surgical procedures used to treat tricuspid stenosis include valvotomy and valve replacement or repair. Valvotomy is performed using 1, 2, or 3 balloons. While some stenosis may persist, the change in valve area&#x000a0;significantly reduces&#x000a0;the transvalvular pressure gradient and right atrial pressure.<xref ref-type="bibr" rid="article-30598.r37">[37]</xref> Valve area generally increases by 1&#x000a0;to 2 cm2.<xref ref-type="bibr" rid="article-30598.r38">[38]</xref> Bioprosthetic valve stenosis can be treated with balloon valvotomy or valve-in-valve replacement.</p>
        <p>Tricuspid valve surgery includes repair or replacement. Surgery is usually reserved for cases with concomitant mitral valve involvement.&#x000a0;Repair should be attempted when reasonable. Sometimes, a simple open commissurotomy suffices. When repair is not an option, valve replacement&#x000a0;may be&#x000a0;performed with an open approach. No differences in long-term outcomes have been established between bioprosthetic and mechanical valves.<xref ref-type="bibr" rid="article-30598.r39">[39]</xref> However, a mechanical valve is preferred over a bioprosthetic carcinoid syndrome to avoid rapid degeneration.</p>
        <p>Tricuspid valve surgery is indicated for symptomatic severe tricuspid stenosis accompanied by tricuspid regurgitation (eg, rheumatic and carcinoid heart diseases), as percutaneous balloon tricuspid commissurotomy may worsen regurgitation. The operative mortality for isolated tricuspid stenosis is significant and increases if performed with other valvular surgery (10% and 16%, respectively).<xref ref-type="bibr" rid="article-30598.r40">[40]</xref></p>
      </sec>
      <sec id="article-30598.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Diseases that can delay right atrial emptying during diastole and mimic tricuspid stenosis include but are not limited to the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiac mass-occupying lesions or&#x000a0;tumors</p>
          </list-item>
          <list-item>
            <p>Thrombotic events or emboli</p>
          </list-item>
          <list-item>
            <p>Atrial myxoma/rhabdomyoma</p>
          </list-item>
          <list-item>
            <p>Congenital&#x000a0;membranes causing supravalvular obstruction</p>
          </list-item>
          <list-item>
            <p>Tricuspid atresia</p>
          </list-item>
          <list-item>
            <p>Endocarditis with large vegetation near or around the right ventricular outflow tract</p>
          </list-item>
          <list-item>
            <p>Endomyocardial fibrosis/Loeffler endocarditis</p>
          </list-item>
        </list>
        <p>Conditions that impair right-sided heart filling and produce similar symptoms and physical findings to those with tricuspid stenosis include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Restrictive cardiomyopathy</p>
          </list-item>
          <list-item>
            <p>Pericarditis (effusive-constrictive vs constrictive)&#x000a0;<xref ref-type="bibr" rid="article-30598.r41">[41]</xref></p>
          </list-item>
        </list>
        <p>A good clinical evaluation and judicious use of diagnostic exams can help distinguish these conditions and determine the appropriate management approach.</p>
      </sec>
      <sec id="article-30598.s10" sec-type="Staging">
        <title>Staging</title>
        <p>Clinical symptoms, hemodynamic and echocardiographic assessment, and valve anatomy determine the stage of tricuspid stenosis.&#x000a0;The&#x000a0;staging is as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>A: Patients at risk for the disease</p>
          </list-item>
          <list-item>
            <p>B: Progressive disease but mild-to-moderate&#x000a0;and asymptomatic</p>
          </list-item>
          <list-item>
            <p>C: Severe but asymptomatic disease</p>
          </list-item>
          <list-item>
            <p>D: Severe and symptomatic disease&#x000a0;<xref ref-type="bibr" rid="article-30598.r33">[33]</xref></p>
          </list-item>
        </list>
        <p>Stages A and B are usually asymptomatic and do not warrant intervention. Adapted from&#x000a0;the American Heart Association executive summary on valvular heart diseases and Nishimura et al, the staging of severe&#x000a0;tricuspid stenosis (stages C &#x00026; D) is elucidated in Table 1. (See&#x000a0;<bold>Table 1. </bold>Staging of Severe Tricuspid Stenosis.)</p>
        <table-wrap id="article-30598.table0" position="float" orientation="portrait">
          <caption>
            <title>Table 1. Staging of Severe Tricuspid Stenosis</title>
          </caption>
          <table style="height: 200px;" border="1" cellspacing="1" cellpadding="2">
            <tbody>
              <tr>
                <td style="width: 35.1719px; text-align: center;" rowspan="1" colspan="1">
<bold>Stage</bold>
</td>
                <td style="width: 58.3594px; text-align: center;" rowspan="1" colspan="1">
<bold>Type</bold>
</td>
                <td style="width: 114px; text-align: center;" rowspan="1" colspan="1">
<bold>Anatomy</bold>
</td>
                <td style="width: 186.719px; text-align: center;" rowspan="1" colspan="1">
<bold>Hemodynamics</bold>
</td>
                <td style="width: 122.875px; text-align: center;" rowspan="1" colspan="1">
<bold>Changes</bold>
</td>
                <td style="width: 244.875px; text-align: center;" rowspan="1" colspan="1">
<bold>Patient Complaints</bold>
</td>
              </tr>
              <tr>
                <td style="width: 35.1719px; text-align: center;" rowspan="1" colspan="1">C &#x00026; D</td>
                <td style="width: 58.3594px; text-align: center;" rowspan="1" colspan="1">Severe stenosis</td>
                <td style="width: 114px; text-align: center;" rowspan="1" colspan="1">Leaflets: Calcified or thickened and distorted</td>
                <td style="width: 186.719px; text-align: center;" rowspan="1" colspan="1">
<p>Pressure half-time &#x02265;190 ms (pulmonary hypertension)</p>
<p>Tricuspid valve area is less than or equal to 1&#x000a0;cm<sup>2</sup></p>
</td>
                <td style="width: 122.875px; text-align: center;" rowspan="1" colspan="1">
<p>Right atrial or inferior vena cava enlargement</p>
</td>
                <td style="width: 244.875px; text-align: center;" rowspan="1" colspan="1">
<p>Silent disease</p>
<p>or</p>
<p>Variable complaints depending on the degree of pulmonary hypertension and systemic venous congestion&#x000a0;</p>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-30598.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The underlying cause and the degree of ventricular dysfunction primarily determine the prognosis for tricuspid stenosis. Most patients with isolated tricuspid stenosis who undergo intervention have a good prognosis.<xref ref-type="bibr" rid="article-30598.r20">[20]</xref> However, substantial evidence on long-term outcomes is lacking due to the rarity of this condition.</p>
      </sec>
      <sec id="article-30598.s12" sec-type="Complications">
        <title>Complications</title>
        <p>The complications of tricuspid stenosis include atrial fibrillation, heart failure, liver failure, and infective endocarditis. Early treatment and continuous monitoring can minimize the risk of these complications.</p>
      </sec>
      <sec id="article-30598.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>
<bold>Patient Education</bold>
</p>
        <p>Educating patients about tricuspid stenosis is crucial for managing the condition effectively and improving their quality of life. Key points to cover include the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Explain that tricuspid stenosis is a narrowing of the tricuspid valve, which impedes blood flow from the right atrium to the right ventricle, causing systemic congestion and elevated right atrial pressure.</p>
          </list-item>
          <list-item>
            <p>Patients should be aware of common symptoms, such as fatigue, exertional dyspnea, generalized weakness, exertional syncope, and signs of systemic congestion like swelling in the abdomen and legs.</p>
          </list-item>
          <list-item>
            <p>Affected individuals must be educated about potential causes, including rheumatic heart disease, carcinoid syndrome, SLE, APAS, and congenital anomalies. The importance of managing underlying conditions to prevent progression must be emphasized.</p>
          </list-item>
          <list-item>
            <p>Encourage a heart-healthy lifestyle, including a balanced diet low in sodium to reduce fluid retention, regular physical activity, and avoiding smoking and excessive alcohol consumption.</p>
          </list-item>
          <list-item>
            <p>Discuss the importance of adhering to prescribed medications and regularly monitoring their condition. Explain the role of diuretics in managing fluid overload and anticoagulants in patients with an&#x000a0;increased&#x000a0;thromboembolism risk.</p>
          </list-item>
          <list-item>
            <p>Educate patients on recognizing worsening symptoms, such as increased shortness of breath, severe fatigue, or sudden weight gain, and the importance of seeking prompt medical attention.</p>
          </list-item>
        </list>
        <p>
<bold>Deterrence</bold>
</p>
        <p>Preventing the progression of tricuspid stenosis and associated complications involves several strategies:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stress the importance of early diagnosis and treatment of conditions leading to tricuspid stenosis, such as rheumatic fever. Prompt treatment can prevent valve damage.</p>
          </list-item>
          <list-item>
            <p>Encourage regular follow-up appointments with a cardiologist to monitor the progression of the disease and adjust treatments as necessary. Echocardiograms and other diagnostic tests can help track valve function and heart health.</p>
          </list-item>
          <list-item>
            <p>Recommend vaccinations, such as influenza and pneumococcal, to prevent infections that can potentially exacerbate heart conditions.</p>
          </list-item>
          <list-item>
            <p>Advise patients to manage comorbid conditions like hypertension, diabetes, and hyperlipidemia effectively to reduce the overall burden on the heart.</p>
          </list-item>
          <list-item>
            <p>Educate about the importance of maintaining good dental hygiene and treating infections promptly, as bacterial endocarditis can worsen valvular heart disease.</p>
          </list-item>
        </list>
        <p>Healthcare professionals can help mitigate the disease's impact and improve patient outcomes by equipping patients with knowledge about tricuspid stenosis and implementing deterrence strategies.</p>
      </sec>
      <sec id="article-30598.s14" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>In cases of congenital tricuspid stenosis with pulmonary valvular atresia and an intact ventricular septum, surgical interventions to enlarge the right ventricular outflow tract, such as myocardial resection, pulmonary valvotomy, partial valvectomy, and patching, may inadvertently exacerbate tricuspid stenosis. This occurrence may be due to the preexisting, small, and sometimes abnormal tricuspid valve and annulus, which may not adequately handle the increased blood flow postoperatively. Consequently, patients can develop significant tricuspid stenosis, resulting in low cardiac output and potentially leading to postoperative mortality.</p>
      </sec>
      <sec id="article-30598.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Effective management of tricuspid stenosis requires interprofessional communication and coordinated care. Physicians, including cardiac surgeons, interventional cardiologists, and cardiovascular imaging specialists, must collaborate to provide accurate diagnosis and optimal treatment plans. The cardiovascular imaging specialist plays a crucial role in initial and ongoing assessments using echocardiography and other imaging modalities to evaluate valve morphology and function. Interventional cardiologists and cardiac surgeons work together to decide whether surgical or percutaneous interventions are necessary, ensuring that the chosen strategy aligns with the patient's overall health status and comorbidities. This collaboration is crucial for planning and executing complex procedures, such as valve repair or replacement, and managing potential complications.</p>
        <p>Advanced practitioners and nurses are integral to patient education, preoperative preparation, and postoperative care, ensuring patients understand their condition, treatment options, and necessary lifestyle adjustments. These professionals monitor the patient's progress,&#x000a0;treat symptoms, and provide emotional support, vital for recovery. Pharmacists contribute by managing anticoagulation therapy and other medications to optimize patient outcomes and minimize risks associated with polypharmacy.</p>
        <p>Clear, consistent communication among all team members through activities that include regular interdisciplinary meetings and shared electronic health records enhances patient safety, care coordination, and overall team performance. This collaborative, patient-centered approach ensures comprehensive care that addresses the medical and emotional needs of patients with tricuspid stenosis, improving outcomes and quality of life.</p>
      </sec>
      <sec id="article-30598.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=30598&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=30598">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/tricuspid-stenosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=30598">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/30598/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=30598">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-30598.s17">
        <fig id="article-30598.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Tricuspid Stenosis on Transthoracic Echocardiography Contributed by Pirbhat Shams, M.B.B.S., F.C.P.S.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="MPG__TS" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-30598.s18">
        <title>References</title>
        <ref id="article-30598.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Some observations on mitral and aortic valve disease.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>282</fpage>
            <page-range>282-99</page-range>
            <pub-id pub-id-type="pmid">18628928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asmarats</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Taramasso</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rod&#x000e9;s-Cabau</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Tricuspid valve disease: diagnosis, prognosis and management of a rapidly evolving field.</article-title>
            <source>Nat Rev Cardiol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>9</issue>
            <fpage>538</fpage>
            <page-range>538-554</page-range>
            <pub-id pub-id-type="pmid">30988448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rashid</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Parvin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Islam</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Monwar</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Karmoker</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Parveen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shakil</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Hasan</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Pattern and Extent of Tricuspid Valve Involvement in Chronic Rheumatic Heart Disease.</article-title>
            <source>Mymensingh Med J</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>120</fpage>
            <page-range>120-125</page-range>
            <pub-id pub-id-type="pmid">29459602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waller</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fess</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pathology of tricuspid valve stenosis and pure tricuspid regurgitation--Part I.</article-title>
            <source>Clin Cardiol</source>
            <year>1995</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>2</issue>
            <fpage>97</fpage>
            <page-range>97-102</page-range>
            <pub-id pub-id-type="pmid">7720297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pellikka</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Tajik</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Khandheria</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Seward</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Callahan</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Pitot</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Kvols</surname>
                <given-names>LK</given-names>
              </name>
            </person-group>
            <article-title>Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.</article-title>
            <source>Circulation</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>87</volume>
            <issue>4</issue>
            <fpage>1188</fpage>
            <page-range>1188-96</page-range>
            <pub-id pub-id-type="pmid">7681733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mocumbi</surname>
                <given-names>AO</given-names>
              </name>
            </person-group>
            <article-title>Right ventricular endomyocardial fibrosis (2013 Grover Conference series).</article-title>
            <source>Pulm Circ</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>363</fpage>
            <page-range>363-9</page-range>
            <pub-id pub-id-type="pmid">25621149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x0015e;a&#x0015f;k&#x00131;n</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>D&#x000fc;zyol</surname>
                <given-names>&#x000c7;</given-names>
              </name>
              <name>
                <surname>&#x000d6;zcan</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Aksoy</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Right atrial myxoma mimicking tricuspid stenosis.</article-title>
            <source>BMJ Case Rep</source>
            <year>2015</year>
            <month>Aug</month>
            <day>13</day>
            <volume>2015</volume>
            <pub-id pub-id-type="pmid">26272962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seibert</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Rettenmier</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Waller</surname>
                <given-names>BF</given-names>
              </name>
              <name>
                <surname>Battle</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>WC</given-names>
              </name>
            </person-group>
            <article-title>Osteogenic sarcoma metastatic to the heart.</article-title>
            <source>Am J Med</source>
            <year>1982</year>
            <month>Jul</month>
            <volume>73</volume>
            <issue>1</issue>
            <fpage>136</fpage>
            <page-range>136-41</page-range>
            <pub-id pub-id-type="pmid">6953763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McAllister</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Fenoglio</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Cardiac involvement in Whipple's disease.</article-title>
            <source>Circulation</source>
            <year>1975</year>
            <month>Jul</month>
            <volume>52</volume>
            <issue>1</issue>
            <fpage>152</fpage>
            <page-range>152-6</page-range>
            <pub-id pub-id-type="pmid">48435</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khatib</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Blumenfeld</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Bronshtein</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Early prenatal diagnosis of tricuspid stenosis.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>207</volume>
            <issue>5</issue>
            <fpage>e6</fpage>
            <page-range>e6-8</page-range>
            <pub-id pub-id-type="pmid">22964066</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gur</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Odabasi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kunt</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Kunt</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Isolated tricuspid valve repair for Libman-Sacks endocarditis.</article-title>
            <source>Echocardiography</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>E166</fpage>
            <page-range>E166-8</page-range>
            <pub-id pub-id-type="pmid">24661289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Hijji</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoon Park</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>El Sabbagh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Maleszewski</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Borgeson</surname>
                <given-names>DD</given-names>
              </name>
            </person-group>
            <article-title>The Forgotten Valve: Isolated Severe Tricuspid Valve Stenosis.</article-title>
            <source>Circulation</source>
            <year>2015</year>
            <month>Aug</month>
            <day>18</day>
            <volume>132</volume>
            <issue>7</issue>
            <fpage>e123</fpage>
            <page-range>e123-5</page-range>
            <pub-id pub-id-type="pmid">26283605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirata</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tengan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wake</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ishimine</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yasumoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Nakasu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mototake</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Bioprosthetic tricuspid valve stenosis: a case series.</article-title>
            <source>Eur Heart J Case Rep</source>
            <year>2019</year>
            <month>Sep</month>
            <day>01</day>
            <volume>3</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">31367735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Surapaneni</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vinales</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Najib</surname>
                <given-names>MQ</given-names>
              </name>
              <name>
                <surname>Chaliki</surname>
                <given-names>HP</given-names>
              </name>
            </person-group>
            <article-title>Valvular heart disease with the use of fenfluramine-phentermine.</article-title>
            <source>Tex Heart Inst J</source>
            <year>2011</year>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>581</fpage>
            <page-range>581-3</page-range>
            <pub-id pub-id-type="pmid">22163141</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tomita</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine.</article-title>
            <source>Chest</source>
            <year>2002</year>
            <month>Feb</month>
            <volume>121</volume>
            <issue>2</issue>
            <fpage>649</fpage>
            <page-range>649-52</page-range>
            <pub-id pub-id-type="pmid">11834685</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gardin</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Schumacher</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Constantine</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine.</article-title>
            <source>JAMA</source>
            <year>2000</year>
            <month>Apr</month>
            <day>05</day>
            <volume>283</volume>
            <issue>13</issue>
            <fpage>1703</fpage>
            <page-range>1703-9</page-range>
            <pub-id pub-id-type="pmid">10755496</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Misch</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Development of heart valve lesions during methysergide therapy.</article-title>
            <source>Br Med J</source>
            <year>1974</year>
            <month>May</month>
            <day>18</day>
            <volume>2</volume>
            <issue>5915</issue>
            <fpage>365</fpage>
            <page-range>365-6</page-range>
            <pub-id pub-id-type="pmid">4835843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rouaud</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Calder</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Hasler</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.</article-title>
            <source>J Psychopharmacol</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-224</page-range>
            <pub-id pub-id-type="pmid">38214279</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tao</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kotick</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Lincoln</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Heart valve development, maintenance, and disease: the role of endothelial cells.</article-title>
            <source>Curr Top Dev Biol</source>
            <year>2012</year>
            <volume>100</volume>
            <fpage>203</fpage>
            <page-range>203-32</page-range>
            <pub-id pub-id-type="pmid">22449845</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roguin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rinkevich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Milo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Markiewicz</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Reisner</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Long-term follow-up of patients with severe rheumatic tricuspid stenosis.</article-title>
            <source>Am Heart J</source>
            <year>1998</year>
            <month>Jul</month>
            <volume>136</volume>
            <issue>1</issue>
            <fpage>103</fpage>
            <page-range>103-8</page-range>
            <pub-id pub-id-type="pmid">9665226</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Manjunath</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Srinivas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ravindranath</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Dhanalakshmi</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Incidence and patterns of valvular heart disease in a tertiary care high-volume cardiac center: a single center experience.</article-title>
            <source>Indian Heart J</source>
            <year>2014</year>
            <season>May-Jun</season>
            <volume>66</volume>
            <issue>3</issue>
            <fpage>320</fpage>
            <page-range>320-6</page-range>
            <pub-id pub-id-type="pmid">24973838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hinton</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Lincoln</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Deutsch</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Osinska</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Manning</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Benson</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Yutzey</surname>
                <given-names>KE</given-names>
              </name>
            </person-group>
            <article-title>Extracellular matrix remodeling and organization in developing and diseased aortic valves.</article-title>
            <source>Circ Res</source>
            <year>2006</year>
            <month>Jun</month>
            <day>09</day>
            <volume>98</volume>
            <issue>11</issue>
            <fpage>1431</fpage>
            <page-range>1431-8</page-range>
            <pub-id pub-id-type="pmid">16645142</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Waggoner</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>de las Fuentes</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Davila-Roman</surname>
                <given-names>VG</given-names>
              </name>
            </person-group>
            <article-title>Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2009</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>8</issue>
            <fpage>883</fpage>
            <page-range>883-9</page-range>
            <pub-id pub-id-type="pmid">19553085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moaref</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Afifi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rezaian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rezaian</surname>
                <given-names>GR</given-names>
              </name>
            </person-group>
            <article-title>Isolated tricuspid valve Libman-Sacks endocarditis and valvular stenosis: unusual manifestations of systemic lupus erythematosus.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>341.e3</fpage>
            <page-range>341.e3-5</page-range>
            <pub-id pub-id-type="pmid">19836204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Raney</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Tricuspid valve disease.</article-title>
            <source>Curr Probl Cardiol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>47</fpage>
            <page-range>47-84</page-range>
            <pub-id pub-id-type="pmid">18222317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coffey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rayner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Prendergast</surname>
                <given-names>BD</given-names>
              </name>
            </person-group>
            <article-title>Right-sided valve disease.</article-title>
            <source>Int J Clin Pract</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>68</volume>
            <issue>10</issue>
            <fpage>1221</fpage>
            <page-range>1221-6</page-range>
            <pub-id pub-id-type="pmid">25269950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stapleton</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Natural history of chronic valvular disease.</article-title>
            <source>Cardiovasc Clin</source>
            <year>1986</year>
            <volume>16</volume>
            <issue>2</issue>
            <fpage>105</fpage>
            <page-range>105-47</page-range>
            <pub-id pub-id-type="pmid">3742519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trombara</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bergonti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toscano</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Dalla Cia</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Assanelli</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Polvani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bartorelli</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Bloody tricuspid stenosis: case report of an uncommon cause of haemoptysis.</article-title>
            <source>Eur Heart J Case Rep</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>ytaa537</fpage>
            <pub-id pub-id-type="pmid">33598616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassan</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Palaskas</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Agha</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Iliescu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lopez-Mattei</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yusuf</surname>
                <given-names>SW</given-names>
              </name>
            </person-group>
            <article-title>Carcinoid Heart Disease: a Comprehensive Review.</article-title>
            <source>Curr Cardiol Rep</source>
            <year>2019</year>
            <month>Nov</month>
            <day>19</day>
            <volume>21</volume>
            <issue>11</issue>
            <fpage>140</fpage>
            <pub-id pub-id-type="pmid">31745664</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r30">
          <label>30</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Applefeld</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <chapter-title>The Jugular Venous Pressure and Pulse Contour</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Walker</surname>
                <given-names>HK</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>WD</given-names>
              </name>
              <name>
                <surname>Hurst</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <source>Clinical Methods: The History, Physical, and Laboratory Examinations</source>
            <edition>3rd</edition>
            <publisher-name>Butterworths</publisher-name>
            <publisher-loc>Boston</publisher-loc>
            <year>1990</year>
            <pub-id pub-id-type="pmid">21250143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baumgartner</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bermejo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chambers</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Evangelista</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Griffin</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Iung</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Pellikka</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Qui&#x000f1;ones</surname>
                <given-names>M</given-names>
              </name>
              <collab>American Society of Echocardiography</collab>
              <collab>European Association of Echocardiography</collab>
            </person-group>
            <article-title>Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice.</article-title>
            <source>J Am Soc Echocardiogr</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-23; quiz 101-2</page-range>
            <pub-id pub-id-type="pmid">19130998</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morgan</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Forker</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Coates</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>Isolated tricuspid stenosis.</article-title>
            <source>Circulation</source>
            <year>1971</year>
            <month>Oct</month>
            <volume>44</volume>
            <issue>4</issue>
            <fpage>729</fpage>
            <page-range>729-32</page-range>
            <pub-id pub-id-type="pmid">5094152</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nishimura</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Otto</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Bonow</surname>
                <given-names>RO</given-names>
              </name>
              <name>
                <surname>Carabello</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Erwin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Guyton</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>O'Gara</surname>
                <given-names>PT</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Skubas</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Sorajja</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sundt</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JD</given-names>
              </name>
              <collab>American College of Cardiology/American Heart Association Task Force on Practice Guidelines</collab>
            </person-group>
            <article-title>2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2014</year>
            <month>Jun</month>
            <day>10</day>
            <volume>63</volume>
            <issue>22</issue>
            <fpage>e57</fpage>
            <page-range>e57-185</page-range>
            <pub-id pub-id-type="pmid">24603191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adler</surname>
                <given-names>DS</given-names>
              </name>
            </person-group>
            <article-title>Non-functional tricuspid valve disease.</article-title>
            <source>Ann Cardiothorac Surg</source>
            <year>2017</year>
            <month>May</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>204</fpage>
            <page-range>204-213</page-range>
            <pub-id pub-id-type="pmid">28706863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seghatol</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Rigolin</surname>
                <given-names>VH</given-names>
              </name>
            </person-group>
            <article-title>Appetite suppressants and valvular heart disease.</article-title>
            <source>Curr Opin Cardiol</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>486</fpage>
            <page-range>486-92</page-range>
            <pub-id pub-id-type="pmid">12357124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cevasco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shekar</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Surgical management of tricuspid stenosis.</article-title>
            <source>Ann Cardiothorac Surg</source>
            <year>2017</year>
            <month>May</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>275</fpage>
            <page-range>275-282</page-range>
            <pub-id pub-id-type="pmid">28706872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Orbe</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Sobrino</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Arcas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Peinado</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Frutos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Blazquez</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Mat&#x000e9;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sobrino</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Initial outcome of percutaneous balloon valvuloplasty in rheumatic tricuspid valve stenosis.</article-title>
            <source>Am J Cardiol</source>
            <year>1993</year>
            <month>Feb</month>
            <day>01</day>
            <volume>71</volume>
            <issue>4</issue>
            <fpage>353</fpage>
            <page-range>353-4</page-range>
            <pub-id pub-id-type="pmid">8427185</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ribeiro</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Al Zaibag</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Al Kasab</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Idris</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Halim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abdullah</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shahed</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous double balloon valvotomy for rheumatic tricuspid stenosis.</article-title>
            <source>Am J Cardiol</source>
            <year>1988</year>
            <month>Mar</month>
            <day>01</day>
            <volume>61</volume>
            <issue>8</issue>
            <fpage>660</fpage>
            <page-range>660-2</page-range>
            <pub-id pub-id-type="pmid">3344697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kunadian</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Vijayalakshmi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Balasubramanian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dunning</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Should the tricuspid valve be replaced with a mechanical or biological valve?</article-title>
            <source>Interact Cardiovasc Thorac Surg</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>551</fpage>
            <page-range>551-7</page-range>
            <pub-id pub-id-type="pmid">17669933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rankin</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Gammie</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>FH</given-names>
              </name>
              <collab>Society of Thoracic Surgeons Adult Cardiac Surgical Database</collab>
            </person-group>
            <article-title>Fifteen-year outcome trends for valve surgery in North America.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>91</volume>
            <issue>3</issue>
            <fpage>677</fpage>
            <page-range>677-84; discussion p 684</page-range>
            <pub-id pub-id-type="pmid">21352979</pub-id>
          </element-citation>
        </ref>
        <ref id="article-30598.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McGinn</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Zipes</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Constrictive pericarditis causing tricuspid stenosis.</article-title>
            <source>Arch Intern Med</source>
            <year>1972</year>
            <month>Mar</month>
            <volume>129</volume>
            <issue>3</issue>
            <fpage>487</fpage>
            <page-range>487-90</page-range>
            <pub-id pub-id-type="pmid">4259627</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
